Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial

Paramasivam SS 1 , Chinna K 2 , Singh AKK 3 , Ratnasingam J 1 , Ibrahim L 1 , Lim LL 1 Show all authors , Tan ATB 1 , Chan SP 1 , Tan PC 4 , Omar SZ 3 , Bilous RW 5 , Vethakkan SR 1

Affiliations 

  • 1 Department of Medicine, University Malaya Medical Centre, Kuala Lumpur
  • 2 Department of Social and Preventive Medicine, University Malaya Medical Centre, Kuala Lumpur
  • 3 Department of Medicine, Serdang Hospital, Selangor
  • 4 Department of Obstetrics and Gynaecology, University Malaya Medical Centre, Kuala Lumpur
  • 5 Newcastle University Malaysia (NUMed), Johor, Malaysia
Diabet Med, 2018 08;35(8):1118-1129.
PMID: 29663517 DOI: 10.1111/dme.13649

Abstract

AIMS: To determine if therapeutic, retrospective continuous glucose monitoring (CGM) improves HbA1c with less hypoglycaemia in women with insulin-treated gestational diabetes mellitus (GDM).

METHODS: This prospective, randomized controlled, open-label trial evaluated 50 women with insulin-treated GDM randomized to either retrospective CGM (6-day sensor) at 28, 32 and 36 weeks' gestation (Group 1, CGM, n = 25) or usual antenatal care without CGM (Group 2, control, n = 25). All women performed seven-point capillary blood glucose (CBG) profiles at least 3 days per week and recorded hypoglycaemic events (symptomatic and asymptomatic CBG

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications